Muscle Spasm Treatment Market, Global Outlook and Forecast 2022-2028

February 2022 | 66 pages | ID: M9CC3E046C99EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Muscle Spasm Treatment in Global, including the following market information:

Global Muscle Spasm Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Muscle Spasm Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Muscle Spasm Treatment include Eisai Co., Ltd., Novartis International AG, GlaxoSmithKline plc, AstraZeneca plc, Pfizer, Inc. and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Muscle Spasm Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Muscle Spasm Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Muscle Spasm Treatment Market Segment Percentages, by Type, 2021 (%)

• Drug
• Service

Global Muscle Spasm Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Muscle Spasm Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Muscle Spasm Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Muscle Spasm Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Muscle Spasm Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Muscle Spasm Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eisai Co., Ltd.
• Novartis International AG
• GlaxoSmithKline plc
• AstraZeneca plc
• Pfizer, Inc.
• Roche

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Muscle Spasm Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Muscle Spasm Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MUSCLE SPASM TREATMENT OVERALL MARKET SIZE

2.1 Global Muscle Spasm Treatment Market Size: 2021 VS 2028
2.2 Global Muscle Spasm Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Muscle Spasm Treatment Players in Global Market
3.2 Top Global Muscle Spasm Treatment Companies Ranked by Revenue
3.3 Global Muscle Spasm Treatment Revenue by Companies
3.4 Top 3 and Top 5 Muscle Spasm Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Muscle Spasm Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Muscle Spasm Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Muscle Spasm Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Muscle Spasm Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Muscle Spasm Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drug
  4.1.3 Service
4.2 By Type - Global Muscle Spasm Treatment Revenue & Forecasts
  4.2.1 By Type - Global Muscle Spasm Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Muscle Spasm Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Muscle Spasm Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Muscle Spasm Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global Muscle Spasm Treatment Revenue & Forecasts
  5.2.1 By Application - Global Muscle Spasm Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Muscle Spasm Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Muscle Spasm Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Muscle Spasm Treatment Market Size, 2021 & 2028
6.2 By Region - Global Muscle Spasm Treatment Revenue & Forecasts
  6.2.1 By Region - Global Muscle Spasm Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Muscle Spasm Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Muscle Spasm Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Muscle Spasm Treatment Revenue, 2017-2028
  6.3.2 US Muscle Spasm Treatment Market Size, 2017-2028
  6.3.3 Canada Muscle Spasm Treatment Market Size, 2017-2028
  6.3.4 Mexico Muscle Spasm Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Muscle Spasm Treatment Revenue, 2017-2028
  6.4.2 Germany Muscle Spasm Treatment Market Size, 2017-2028
  6.4.3 France Muscle Spasm Treatment Market Size, 2017-2028
  6.4.4 U.K. Muscle Spasm Treatment Market Size, 2017-2028
  6.4.5 Italy Muscle Spasm Treatment Market Size, 2017-2028
  6.4.6 Russia Muscle Spasm Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Muscle Spasm Treatment Market Size, 2017-2028
  6.4.8 Benelux Muscle Spasm Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Muscle Spasm Treatment Revenue, 2017-2028
  6.5.2 China Muscle Spasm Treatment Market Size, 2017-2028
  6.5.3 Japan Muscle Spasm Treatment Market Size, 2017-2028
  6.5.4 South Korea Muscle Spasm Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Muscle Spasm Treatment Market Size, 2017-2028
  6.5.6 India Muscle Spasm Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Muscle Spasm Treatment Revenue, 2017-2028
  6.6.2 Brazil Muscle Spasm Treatment Market Size, 2017-2028
  6.6.3 Argentina Muscle Spasm Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Muscle Spasm Treatment Revenue, 2017-2028
  6.7.2 Turkey Muscle Spasm Treatment Market Size, 2017-2028
  6.7.3 Israel Muscle Spasm Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Muscle Spasm Treatment Market Size, 2017-2028
  6.7.5 UAE Muscle Spasm Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eisai Co., Ltd.
  7.1.1 Eisai Co., Ltd. Corporate Summary
  7.1.2 Eisai Co., Ltd. Business Overview
  7.1.3 Eisai Co., Ltd. Muscle Spasm Treatment Major Product Offerings
  7.1.4 Eisai Co., Ltd. Muscle Spasm Treatment Revenue in Global Market (2017-2022)
  7.1.5 Eisai Co., Ltd. Key News
7.2 Novartis International AG
  7.2.1 Novartis International AG Corporate Summary
  7.2.2 Novartis International AG Business Overview
  7.2.3 Novartis International AG Muscle Spasm Treatment Major Product Offerings
  7.2.4 Novartis International AG Muscle Spasm Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis International AG Key News
7.3 GlaxoSmithKline plc
  7.3.1 GlaxoSmithKline plc Corporate Summary
  7.3.2 GlaxoSmithKline plc Business Overview
  7.3.3 GlaxoSmithKline plc Muscle Spasm Treatment Major Product Offerings
  7.3.4 GlaxoSmithKline plc Muscle Spasm Treatment Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline plc Key News
7.4 AstraZeneca plc
  7.4.1 AstraZeneca plc Corporate Summary
  7.4.2 AstraZeneca plc Business Overview
  7.4.3 AstraZeneca plc Muscle Spasm Treatment Major Product Offerings
  7.4.4 AstraZeneca plc Muscle Spasm Treatment Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca plc Key News
7.5 Pfizer, Inc.
  7.5.1 Pfizer, Inc. Corporate Summary
  7.5.2 Pfizer, Inc. Business Overview
  7.5.3 Pfizer, Inc. Muscle Spasm Treatment Major Product Offerings
  7.5.4 Pfizer, Inc. Muscle Spasm Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer, Inc. Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Muscle Spasm Treatment Major Product Offerings
  7.6.4 Roche Muscle Spasm Treatment Revenue in Global Market (2017-2022)
  7.6.5 Roche Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Muscle Spasm Treatment Market Opportunities & Trends in Global Market
Table 2. Muscle Spasm Treatment Market Drivers in Global Market
Table 3. Muscle Spasm Treatment Market Restraints in Global Market
Table 4. Key Players of Muscle Spasm Treatment in Global Market
Table 5. Top Muscle Spasm Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Muscle Spasm Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Muscle Spasm Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Muscle Spasm Treatment Product Type
Table 9. List of Global Tier 1 Muscle Spasm Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Muscle Spasm Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Muscle Spasm Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Muscle Spasm Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Muscle Spasm Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Muscle Spasm Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Muscle Spasm Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Muscle Spasm Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Muscle Spasm Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Muscle Spasm Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Muscle Spasm Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Muscle Spasm Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Muscle Spasm Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Muscle Spasm Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Muscle Spasm Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Muscle Spasm Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Eisai Co., Ltd. Corporate Summary
Table 31. Eisai Co., Ltd. Muscle Spasm Treatment Product Offerings
Table 32. Eisai Co., Ltd. Muscle Spasm Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis International AG Corporate Summary
Table 34. Novartis International AG Muscle Spasm Treatment Product Offerings
Table 35. Novartis International AG Muscle Spasm Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline plc Corporate Summary
Table 37. GlaxoSmithKline plc Muscle Spasm Treatment Product Offerings
Table 38. GlaxoSmithKline plc Muscle Spasm Treatment Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca plc Corporate Summary
Table 40. AstraZeneca plc Muscle Spasm Treatment Product Offerings
Table 41. AstraZeneca plc Muscle Spasm Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer, Inc. Corporate Summary
Table 43. Pfizer, Inc. Muscle Spasm Treatment Product Offerings
Table 44. Pfizer, Inc. Muscle Spasm Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Roche Corporate Summary
Table 46. Roche Muscle Spasm Treatment Product Offerings
Table 47. Roche Muscle Spasm Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Muscle Spasm Treatment Segment by Type in 2021
Figure 2. Muscle Spasm Treatment Segment by Application in 2021
Figure 3. Global Muscle Spasm Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Muscle Spasm Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Muscle Spasm Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Muscle Spasm Treatment Revenue in 2021
Figure 8. By Type - Global Muscle Spasm Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Muscle Spasm Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Muscle Spasm Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Muscle Spasm Treatment Revenue Market Share, 2017-2028
Figure 12. US Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Muscle Spasm Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Muscle Spasm Treatment Revenue Market Share, 2017-2028
Figure 24. China Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Muscle Spasm Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Muscle Spasm Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Muscle Spasm Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Eisai Co., Ltd. Muscle Spasm Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis International AG Muscle Spasm Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline plc Muscle Spasm Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca plc Muscle Spasm Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer, Inc. Muscle Spasm Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Muscle Spasm Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)